Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2014-01-24 Regulatory Filings
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings
2014-01-24 English
Other Report or Announcement
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, XTL Biopharmaceuticals Ltd. It reports on the results of general meetings of shareholders and warrant holders, including voting outcomes and resolutions passed. The document is an immediate report providing regulatory information about shareholder meetings and voting results, not a full annual or quarterly report, audit report, or earnings release. It is not a proxy solicitation or AGM presentation but an official announcement of voting results from the general meetings. The document length is 4610 characters, which is relatively short but contains substantive voting results data. Therefore, the best fitting category is Declaration of Voting Results & Voting Rights Announcements (DVA).
2014-01-14 Hebrew (modern)
Other Report or Announcement
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is very short (1721 chars) and explicitly states that it is an 'Other Report or Announcement' under Israeli regulations. Crucially, it states: 'Attached hereto is a report on *Resulotion of the shareholders and warrant (series 2) holders meetings of the Company.*' followed by a PDF filename. This structure indicates that the document itself is an announcement about the publication of a report (shareholder meeting resolutions), rather than the full resolution document. Since the content relates to shareholder meeting results, the most specific category is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). However, given the 'Menu vs Meal' rule, and the fact that this is an announcement attaching the results, it could also be classified as a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the core subject is the resolution of a shareholders' meeting, DVA is the most accurate subject matter classification, but the format strongly suggests RPA. Given the options, DVA covers the content (resolution of shareholder meetings), while RPA covers the format (announcement of attached report). Since the content is highly specific to voting results, I will prioritize DVA, assuming the attached PDF contains the detailed results, and this filing serves as the official notification/publication of those results.
2014-01-14 English
FORM 6-K
Regulatory Filings
2014-01-13 English
Immediate Report
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, XTL Biopharmaceuticals Ltd. It contains a business update about a licensing agreement and clinical development plans for a pharmaceutical asset. The document is not a full annual or quarterly report, nor is it an earnings release or financial supplement. It is a regulatory filing used by foreign companies to report material information to the SEC between annual reports. The content is primarily a business update and licensing announcement, typical of Form 6-K filings. The document length (6876 characters) and content confirm it is not a report publication announcement or certification. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 6-K that do not fit other specific categories.
2014-01-08 Hebrew (modern)
Immediate Report
Report Publication Announcement Classification · 98% confidence The document is very short (1615 chars) and explicitly states, 'Attached hereto is a report on *TASE_8_01_14_isa.pdf*'. This structure—a brief announcement referencing an attached or linked primary document—fits the definition of a Report Publication Announcement (RPA) according to the 'MENU VS MEAL' rule. It is not the full report itself, but the notice of its publication. The filing is made under 'Immediate Report' regulations to the Israel Securities Authority and Tel Aviv Stock Exchange.
2014-01-08 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.